Published in Am J Trop Med Hyg on September 01, 1982
Siderophore-based iron acquisition and pathogen control. Microbiol Mol Biol Rev (2007) 4.87
Interferon gamma-activated human monocytes downregulate transferrin receptors and inhibit the intracellular multiplication of Legionella pneumophila by limiting the availability of iron. J Clin Invest (1989) 3.36
Chloroquine inhibits the intracellular multiplication of Legionella pneumophila by limiting the availability of iron. A potential new mechanism for the therapeutic effect of chloroquine against intracellular pathogens. J Clin Invest (1991) 1.68
Iron-dependent free radical generation from the antimalarial agent artemisinin (qinghaosu). Antimicrob Agents Chemother (1993) 1.50
Deferoxamine and eflornithine (DL-alpha-difluoromethylornithine) in a rat model of Pneumocystis carinii pneumonia. Antimicrob Agents Chemother (1990) 1.24
Identification of the parasite transferrin receptor of Plasmodium falciparum-infected erythrocytes and its acylation via 1,2-diacyl-sn-glycerol. Proc Natl Acad Sci U S A (1986) 1.18
Functional expression of falcipain, a Plasmodium falciparum cysteine proteinase, supports its role as a malarial hemoglobinase. Infect Immun (1995) 1.17
Deferoxamine inhibition of malaria is independent of host iron status. J Exp Med (1988) 1.17
Iron chelators as therapeutic agents against Pneumocystis carinii. Antimicrob Agents Chemother (1994) 1.14
Iron and infection. Br Med J (Clin Res Ed) (1988) 1.12
Iron, anemia and hepcidin in malaria. Front Pharmacol (2014) 1.10
The antimalarial action of desferal involves a direct access route to erythrocytic (Plasmodium falciparum) parasites. J Clin Invest (1993) 1.09
Reversed siderophores act as antimalarial agents. Proc Natl Acad Sci U S A (1991) 0.92
Coxiella burnetii infection increases transferrin receptors on J774A. 1 cells. Infect Immun (1999) 0.91
Superinfection in malaria: Plasmodium shows its iron will. EMBO Rep (2011) 0.91
In vitro activities of novel catecholate siderophores against Plasmodium falciparum. Antimicrob Agents Chemother (1996) 0.87
The role of antioxidants treatment on the pathogenesis of malarial infections: a review. Parasitol Res (2014) 0.86
Iron deficiency protects inbred mice against infection with Plasmodium chabaudi. Infect Immun (1985) 0.84
Effects of zinc-desferrioxamine on Plasmodium falciparum in culture. Antimicrob Agents Chemother (1995) 0.81
ZIPCO, a putative metal ion transporter, is crucial for Plasmodium liver-stage development. EMBO Mol Med (2014) 0.80
Antimalarial action of hydroxamate-based iron chelators and potentiation of desferrioxamine action by reversed siderophores. Antimicrob Agents Chemother (1995) 0.80
Plasmodium drug targets outside the genetic control of the parasite. Curr Pharm Des (2013) 0.79
In vitro potentiation of antibiotic activities by a catecholate iron chelator against chloroquine-resistant Plasmodium falciparum. Antimicrob Agents Chemother (2002) 0.77
Antimalarial iron chelator FBS0701 blocks transmission by Plasmodium falciparum gametocyte activation inhibition. Antimicrob Agents Chemother (2014) 0.77
Erythroferrone contributes to hepcidin repression in a mouse model of malarial anemia. Haematologica (2016) 0.76
Inhibitory effect of novel iron chelator, 1-(N-acetyl-6-aminohexyl)-3-hydroxy-2-methylpyridin-4-one (CM1) and green tea extract on growth of Plasmodium falciparum. Malar J (2015) 0.75
Chemical Determinants of antimalarial activity of reversed siderophores. Antimicrob Agents Chemother (1996) 0.75
Correction of sickle cell disease in transgenic mouse models by gene therapy. Science (2001) 3.25
Evidence for the multicentric origin of the sickle cell hemoglobin gene in Africa. Proc Natl Acad Sci U S A (1984) 2.86
Rosetting of Plasmodium falciparum-infected red blood cells with uninfected red blood cells enhances microvascular obstruction under flow conditions. Blood (1991) 2.18
Shear stress enhances the proteolysis of von Willebrand factor in normal plasma. Blood (1994) 2.12
Brief report: recurrent severe infections caused by a novel leukocyte adhesion deficiency. N Engl J Med (1992) 2.12
Overdiagnosis of 21-hydroxylase late onset congenital adrenal hyperplasia: correlation of corticotropin test and human leukocyte antigen typing. Fertil Steril (1996) 2.09
Polymerase chain reaction amplification applied to the determination of beta-like globin gene cluster haplotypes. Am J Hematol (1989) 2.04
Isoelectric focusing without ampholyte. Biochem Biophys Res Commun (1979) 2.02
Psychological comorbidity and length of stay in the general hospital. Am J Psychiatry (1991) 1.98
Sickle cell anemia day hospital: an approach for the management of uncomplicated painful crises. Blood (2000) 1.95
Difficulties and rewards in family care of the depressed older adult. Gerontologist (1992) 1.94
Hematologically and genetically distinct forms of sickle cell anemia in Africa. The Senegal type and the Benin type. N Engl J Med (1985) 1.90
Ligand-induced conformational dependence of hemoglobin in sickling interactios. J Mol Biol (1971) 1.89
A randomized controlled trial of vitamin D3 supplementation for the prevention of symptomatic upper respiratory tract infections. Epidemiol Infect (2009) 1.87
Common haplotype dependency of high G gamma-globin gene expression and high Hb F levels in beta-thalassemia and sickle cell anemia patients. Proc Natl Acad Sci U S A (1985) 1.85
Microvascular sites and characteristics of sickle cell adhesion to vascular endothelium in shear flow conditions: pathophysiological implications. Proc Natl Acad Sci U S A (1989) 1.79
Monoclonal antibodies to alphaVbeta3 (7E3 and LM609) inhibit sickle red blood cell-endothelium interactions induced by platelet-activating factor. Blood (2000) 1.77
Growth factors regulate the survival and fate of cells derived from human neurospheres. Nat Biotechnol (2001) 1.70
Stimulation of MAP-2 kinase activity in T lymphocytes by anti-CD3 or anti-Ti monoclonal antibody is partially dependent on protein kinase C. J Immunol (1990) 1.70
Membrane knobs are required for the microcirculatory obstruction induced by Plasmodium falciparum-infected erythrocytes. Proc Natl Acad Sci U S A (1985) 1.68
Impaired nitric oxide-mediated vasodilation in transgenic sickle mouse. Am J Physiol Heart Circ Physiol (2000) 1.63
Specific killing of tumor cells in vitro in the presence of normal lymphoid cells and sera from hosts immune to the tumor antigens. Int J Cancer (1972) 1.60
Cognitive and behavioral precursors of schizophrenia. Dev Psychopathol (1999) 1.60
Circulating megakaryocytes and platelet release in the lung. Blood (1965) 1.55
Preliminary report on the use of desferrioxamine in the treatment of Plasmodium falciparum malaria. Am J Hematol (1991) 1.54
Structural bases of the inhibitory effects of hemoglobin F and hemoglobin A2 on the polymerization of hemoglobin S. Proc Natl Acad Sci U S A (1979) 1.50
Heterogeneity of red cells in the sickler: a characteristic with practical clinical and pathophysiological implications. Blood Cells (1982) 1.49
Erythrocytes in sickle cell anemia are heterogeneous in their rheological and hemodynamic characteristics. J Clin Invest (1983) 1.48
The binding of hemoglobin to haptoglobin and its relation to subunit dissociation of hemoglobin. J Biol Chem (1971) 1.44
Polydipsia and tardive dyskinesia in chronic psychiatric patients--related disorders? Am J Psychiatry (1993) 1.43
Decreased sensitivity to insulin-like growth factor I in Turner's syndrome: a study of monocytes and T lymphocytes. Eur J Clin Invest (1997) 1.42
High expression of human beta S- and alpha-globins in transgenic mice: hemoglobin composition and hematological consequences. Proc Natl Acad Sci U S A (1992) 1.42
Erythropoietin and visual hallucinations in patients on dialysis. Psychosomatics (1996) 1.41
Effect of alpha-thalassemia on sickle-cell anemia linked to the Arab-Indian haplotype in India. Am J Hematol (1997) 1.40
Mutations affecting the trichocysts in Paramecium aurelia. I. Morphology and description of the mutants. J Protozool (1974) 1.39
Prevention program of HIV infection in Ethiopian new immigrants to Israel. Acta Paediatr Suppl (1994) 1.38
Neuropsychological functioning and MRI signal hyperintensities in geriatric depression. Am J Psychiatry (1999) 1.37
High expression of human beta S- and alpha-globins in transgenic mice: erythrocyte abnormalities, organ damage, and the effect of hypoxia. Proc Natl Acad Sci U S A (1992) 1.37
Structure and properties of hemoglobin C-Harlem, a human hemoglobin variant with amino acid substitutions in 2 residues of the beta-polypeptide chain. J Biol Chem (1967) 1.34
The -158 site 5' to the G gamma gene and G gamma expression. Blood (1985) 1.34
Hippocampal/amygdala volumes in geriatric depression. Psychol Med (1999) 1.33
Volume-dependent and NEM-stimulated K+,Cl- transport is elevated in oxygenated SS, SC and CC human red cells. FEBS Lett (1986) 1.32
CD-3-mediated activation of MAP-2 kinase can be modified by ligation of the CD4 receptor. Evidence for tyrosine phosphorylation during activation of this kinase. J Immunol (1990) 1.32
Sickling rates of human AS red cells infected in vitro with Plasmodium falciparum malaria. Science (1978) 1.31
High-dose intravenous gamma globulin for autoimmune neutropenia. N Engl J Med (1982) 1.29
The hematologic characteristics of sickle cell anemia bearing the Bantu haplotype: the relationship between G gamma and HbF level. Blood (1987) 1.29
Clinical effects of clozapine in chronic schizophrenia: response to treatment and predictors of outcome. Am J Psychiatry (1994) 1.29
An objective sign in painful crisis in sickle cell anemia: the concomitant reduction of high density red cells. Blood (1984) 1.27
Factors affecting recurrence following resection for Crohn's disease. Dis Colon Rectum (1986) 1.26
Glucose-6-phosphate dehydrogenase deficiency inhibits in vitro growth of Plasmodium falciparum. Proc Natl Acad Sci U S A (1983) 1.25
Plasmodium falciparum: enhanced gametocyte formation in vitro in reticulocyte-rich blood. Exp Parasitol (1999) 1.24
Desferrioxamine suppresses Plasmodium falciparum in Aotus monkeys. Proc Soc Exp Biol Med (1987) 1.23
Chelate mediated transfer of iron from transferrin to desferrioxamine. Br J Haematol (1976) 1.23
Protecting children from lead poisoning and building healthy communities. Am J Public Health (1999) 1.23
SC erythrocytes have an abnormally high intracellular hemoglobin concentration. Pathophysiological consequences. J Clin Invest (1982) 1.18
Clinical efficacy of methylphenidate in conduct disorder with and without attention deficit hyperactivity disorder. Arch Gen Psychiatry (1997) 1.18
Transgenic mice expressing human fetal globin are protected from malaria by a novel mechanism. Blood (1998) 1.18
In vivo demonstration of red cell-endothelial interaction, sickling and altered microvascular response to oxygen in the sickle transgenic mouse. J Clin Invest (1995) 1.15
Osteomyelitis in fractured sternum after cardiopulmonary resuscitation. N Engl J Med (1979) 1.14
Genetic epidemiology of the beta s gene. Baillieres Clin Haematol (1992) 1.14
The effect of beta 73 Asn on the interactions of sickling hemoglobins. Biochim Biophys Acta (1970) 1.14
The effects of clozapine on tardive dyskinesia. Br J Psychiatry (1991) 1.14
Second generation knockout sickle mice: the effect of HbF. Blood (2001) 1.14
Gender and haplotype effects upon hematological manifestations of adult sickle cell anemia. Am J Hematol (1995) 1.13
Beta-chain contact sites in the haemoglobin S polymer. Nature (1980) 1.13
Proteolytic cleavage of recombinant type 2A von Willebrand factor mutants R834W and R834Q: inhibition by doxycycline and by monoclonal antibody VP-1. Blood (1997) 1.12
A second generation transgenic mouse model expressing both hemoglobin S (HbS) and HbS-Antilles results in increased phenotypic severity. Blood (1995) 1.12
Cerebral malaria in mice: demonstration of cytoadherence of infected red blood cells and microrheologic correlates. Am J Trop Med Hyg (1994) 1.11
Postictal and chronic psychoses in patients with temporal lobe epilepsy. Am J Psychiatry (1995) 1.11
Volume-stimulated, Cl(-)-dependent K+ efflux is highly expressed in young human red cells containing normal hemoglobin or HbS. J Membr Biol (1987) 1.10
Clozapine and weight gain. J Clin Psychiatry (1994) 1.09
Vaso-occlusion by sickle cells: evidence for selective trapping of dense red cells. Blood (1986) 1.09
Effects of clozapine on auditory event-related potentials in schizophrenia. Biol Psychiatry (1998) 1.09
Glutathione stability and oxidative stress in P. falciparum infection in vitro: responses of normal and G6PD deficient cells. Biochem Biophys Res Commun (1982) 1.09
On the mechanism for the red-cell accumulation of mefloquine, an antimalarial drug. Biochim Biophys Acta (1984) 1.09
Multimeric composition of endothelial cell-derived von Willebrand factor. Blood (1989) 1.09
Molecular cloning of human protein 4.2: a major component of the erythrocyte membrane. Proc Natl Acad Sci U S A (1990) 1.08
Spectrum of beta thalassemia mutations and their linkage to beta-globin gene haplotypes in the Indo-Mauritians. Am J Hematol (2000) 1.08
Comparison of bifrontal and bitemporal ECT for major depression. Am J Psychiatry (2000) 1.08
Sulfhemoglobinemia. Clinical and molecular aspects. N Engl J Med (1984) 1.08
Oxidation of spectrin and deformability defects in diabetic erythrocytes. Diabetes (1991) 1.07
Deoxygenation inhibits the volume-stimulated, Cl(-)-dependent K+ efflux in SS and young AA cells: a cytosolic Mg2+ modulation. Blood (1987) 1.07
Low-Mr iron isolated from guinea pig reticulocytes as AMP-Fe and ATP-Fe complexes. Biochem J (1989) 1.07
The binding of hemoglobin to membranes of normal and sickle erythrocytes. Biochim Biophys Acta (1975) 1.07
Subject selection biases in clinical trials: data from a multicenter schizophrenia treatment study. J Clin Psychopharmacol (1996) 1.07
The sickle gene polymorphism in North Africa. Blood (1981) 1.06
The pathophysiology of vascular obstruction in the sickle syndromes. Blood Rev (1996) 1.06
Investigation of frontal lobe subregions in first-episode schizophrenia. Psychiatry Res (1999) 1.06
Accuracy of pulse oximetry in sickle cell disease. Am J Respir Crit Care Med (1999) 1.06
An increased Bohr effect in sickle cell anemia. Blood (1979) 1.06
Sickle gene. Its origin and diffusion from West Africa. J Clin Invest (1981) 1.06
Relation between structure and function in Hemoglobin Chesapeake. Biochemistry (1967) 1.04
Transgenic mice expressing human sickle hemoglobin are partially resistant to rodent malaria. Blood (1993) 1.04
Hierarchical diagnosis in chronic schizophrenia: a clinical study of co-occurring syndromes. Schizophr Bull (2000) 1.04
Overexpression of manganese superoxide dismutase protects lung epithelial cells against oxidant injury. Am J Respir Cell Mol Biol (2001) 1.04
Renal nitric oxide synthases in transgenic sickle cell mice. Kidney Int (1996) 1.04